Your AI-Trained Oncology Knowledge Connection!

Metastatic Renal Cell Carcinoma: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management : Episode 15

Safety and Efficacy Data: The KEYNOTE-426 Trial

May 2, 2022

By David Aggen, MD, PhD
Robert S. Alter, MD

Video

Arnab Basu, MD, MPH, FACP discusses data from the KEYNOTE-426 trial of axitinib/pembrolizumab versus sunitinib in metastatic RCC.

EP: 1.Trends in RCC Incidence

EP: 2.RCC Histologies

EP: 3.Risk Models and Prognostic Factors

EP: 4.Metastatic RCC: Prognosis and Recent Advances in Care

EP: 5.Biomarker Testing in RCC: Current Approaches

EP: 6.Biomarker Testing: Methodologies, Sample Types, and Emerging Data

EP: 7.Prognostic Value of Biomarkers in RCC

EP: 8.The Role of Genetic Mutations in Prognosis and Decision-Making

EP: 9.Comparison of Older First-Line, Single-Agent Therapies

EP: 10.Newer First-Line Combination Therapy Options

EP: 11.Evolution of Combination Therapy As The Standard of Care

EP: 12.Patients Suitable for First-Line, Single-Agent Therapy and NCCN-Recommended Regimens

EP: 13.Safety and Efficacy Data: The CheckMate 214 Trial

EP: 14.Safety and Efficacy Data: The JAVELIN Renal 101 Trial

EP: 15.Safety and Efficacy Data: The KEYNOTE-426 Trial

EP: 16.Safety and Efficacy Data: The CheckMate 9ER Trial

EP: 17.Safety and Efficacy Data: The CLEAR Trial

EP: 18.Common Adverse Events with Single-Agent or Combination Therapy

EP: 19.Balancing Treatment Efficacy with Toxicity in Metastatic RCC

EP: 20.Strategies for Prevention and Management of Adverse Events

EP: 21.Patient-Specific Factors Impacting Treatment Choices in RCC

EP: 22.Considerations for Patient-Focused, Shared Decision-Making in RCC

EP: 23.Clinical Pearls on Tailoring Dosing Strategies in Metastatic Kidney Cancer

EP: 24.The Importance of Team-Based Management and Patient Communication

EP: 25.OncView™ Podcast: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management in Metastatic RCC

EP: 26.Reflections on Novel Targets and Emerging Regimens for RCC

EP: 27.Clinical Pearls on Recent Advances and the Future of Treatment in RCC

EP: 28.Recap: Safety and Efficacy of Available Treatment Options and Considerations for Management of RCC

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos

1 expert in this video

1 expert in this video

OncNursingNews.com

TargetedOnc.com

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences

All rights reserved.